| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/10/2000 | EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/10/2000 | EP0998940A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues |
| 05/10/2000 | EP0998930A1 Remedial agent for baldness and other diseases |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 05/10/2000 | EP0998291A1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 05/10/2000 | EP0998289A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
| 05/10/2000 | CN1252795A 4,1-benzoxazepines, their analogues,and their use as somatostatin agonists |
| 05/10/2000 | CN1052238C Conception promoting 19,11 overbridge estratrene |
| 05/09/2000 | CA2151560C Insulin analog formulations |
| 05/09/2000 | CA2112239C Enantiomeric hydroxylated xanthine compounds |
| 05/09/2000 | CA1340985C Peptide derivatives |
| 05/04/2000 | WO2000024911A2 Human phospholipases |
| 05/04/2000 | WO2000024755A1 Ovary-specific genes and proteins |
| 05/04/2000 | WO2000024437A2 Textured and porous silicone rubber |
| 05/04/2000 | WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/04/2000 | WO2000024360A2 Preparation and use of solidified oils |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2348430A1 Ovary-specific genes and proteins |
| 05/04/2000 | CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | CA2346820A1 Preparation and use of solidified oils |
| 05/04/2000 | CA2342337A1 Vaporizing device for administering sterile medication |
| 05/04/2000 | CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/03/2000 | EP0996457A1 Fsh-releasing peptides |
| 05/03/2000 | CN1251838A Samatotropin releasing peptide |
| 05/03/2000 | CN1051930C Use of sea-buckthorn fruit oil in medicine for regulating endocrine function of women |
| 05/02/2000 | US6057422 Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |
| 05/02/2000 | US6056977 Once-a-day controlled release sulfonylurea formulation |
| 05/02/2000 | US6056975 Levothyroxine sodium, polysaccharide |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023420A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents |
| 04/27/2000 | CA2348159A1 Aromatic amine derivatives, their production and use |
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/26/2000 | EP0995748A1 Growth hormone secretagogues |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994708A1 Antagonists of gonadotropin releasing hormone |
| 04/26/2000 | CN1051703C Process for preparing medicinal composition containing oxaspiro [2,5] octane derivatives and its salt thereof |
| 04/25/2000 | US6054453 Hypolipidemic, antihyperglycemic uses. |
| 04/25/2000 | US6054446 17-substituted-17-desoxy-1,3,5-estratrienes. |
| 04/25/2000 | US6054432 Means for treating prostate hypertrophy and prostate cancer |
| 04/20/2000 | WO2000021572A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 04/20/2000 | WO2000021535A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | WO2000021511A2 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/20/2000 | WO2000021503A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/20/2000 | WO2000003742A3 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 04/20/2000 | DE19847968A1 Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit. |
| 04/20/2000 | CA2347225A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | CA2346329A1 Hydrogels and water soluble polymeric carriers for drug delivery |
| 04/20/2000 | CA2311937A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/19/2000 | EP0993831A2 Compounds and compositions for delivering active agents |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020358A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 04/13/2000 | WO2000020024A2 Methods for the treatment of non-thyroid disorders |
| 04/13/2000 | WO2000019987A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | WO2000019975A1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients |
| 04/13/2000 | DE19907094C1 Use of antibodies capable of blocking human thyroid-stimulating hormone receptor to treat hyperthyroidism and endocrine orbitopathy |
| 04/13/2000 | CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | CA2345808A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | CA2345642A1 Methods for the treatment of non-thyroid disorders |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation |
| 04/12/2000 | EP0992510A1 N6 heterocyclic substituted adenosine derivatives |
| 04/12/2000 | EP0991618A1 Selective thyroid hormone analogs |
| 04/12/2000 | EP0991420A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 04/12/2000 | EP0991419A1 Treatment of infertility with leptin receptor ligands |
| 04/12/2000 | EP0991418A1 Method of modulating hypothalamic somatostatin release |
| 04/12/2000 | CN1250373A Composition and method for suppelmenting testosterone in women with symptoms of testosterone deficiency |
| 04/11/2000 | US6048896 For treatment of brain or nervous system disorders |
| 04/11/2000 | US6048884 Antidiabetic agents; hypoglycemic agents |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048869 Reductase inhibitors |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018758A1 Pyrimidone derivatives |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018423A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 04/06/2000 | WO2000018397A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 04/06/2000 | WO2000018388A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018373A1 Core tablet for controlled release of gliclazide after oral administration |
| 04/06/2000 | CA2345988A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 04/06/2000 | CA2345065A1 Pyrimidone derivatives |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2342603A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/05/2000 | EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 04/05/2000 | EP0874812B1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 04/05/2000 | EP0786011B1 Microbiological process for the preparation of 1-unsaturated 17-beta-carboxysubstituted 3-oxo-4-azaandrostan-3-ones |